1. Home
  2. EVI vs SLN Comparison

EVI vs SLN Comparison

Compare EVI & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$17.62

Market Cap

234.7M

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.63

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
SLN
Founded
1959
1994
Country
United States
United Kingdom
Employees
N/A
116
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.7M
236.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
EVI
SLN
Price
$17.62
$6.63
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$35.00
$42.60
AVG Volume (30 Days)
34.1K
194.7K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
1.81%
N/A
EPS Growth
32.43
N/A
EPS
0.31
N/A
Revenue
$389,830,000.00
N/A
Revenue This Year
$15.53
N/A
Revenue Next Year
$3.83
N/A
P/E Ratio
$56.45
N/A
Revenue Growth
10.26
N/A
52 Week Low
$15.61
$4.19
52 Week High
$34.82
$8.40

Technical Indicators

Market Signals
Indicator
EVI
SLN
Relative Strength Index (RSI) 46.11 50.75
Support Level $16.78 $5.76
Resistance Level $21.36 $7.53
Average True Range (ATR) 1.41 0.55
MACD 0.08 -0.02
Stochastic Oscillator 44.51 59.54

Price Performance

Historical Comparison
EVI
SLN

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: